# Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

> **NCT01808534** · PHASE2 · TERMINATED · sponsor: **Indiana University** · enrollment: 5 (actual)

## Conditions studied

- Adult Central Nervous System Germ Cell Tumor
- Adult Teratoma
- Malignant Extragonadal Germ Cell Tumor
- Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
- Extragonadal Seminoma
- Recurrent Malignant Testicular Germ Cell Tumor
- Recurrent Ovarian Germ Cell Tumor
- Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor
- Stage IV Extragonadal Seminoma
- Stage IV Ovarian Germ Cell Tumor

## Interventions

- **DRUG:** palifosfamide

## Key facts

- **NCT ID:** NCT01808534
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Due to Low Accrual
- **Last updated:** 2015-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808534, "Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01808534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*